Obesity and Risk of Incident Left Ventricular Hypertrophy in Community-Dwelling Populations With Hypertension: An Observational Study

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2024 Jun 6

PMID 38842284

Authors

Anping Cai

Lin Liu

Dan Zhou

Songtao Tang

Marijana Tadic

Aletta E Schutte

Yingqing Feng

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to evaluate the association between obesity and risk of incident left ventricular hypertrophy (LVH) in community-dwelling populations with hypertension and investigate whether this association would be attenuated by a lower achieved systolic blood pressure (SBP).

Methods And Results: We used the EMINCA (Echocardiographic Measurements in Normal Chinese Adults) criteria, which were derived from healthy Chinese populations to define LVH. A total of 2069 participants with hypertension and without LVH (obesity 20.4%) were included. The association between obesity and risk of incident LVH was evaluated using Cox proportional hazard models and stratified by achieved follow-up SBP levels (≥140, 130-139, and <130 mm Hg). These analyses were also assessed using the American Society of Echocardiography/European Association of Cardiovascular Imaging criteria, which were derived from European populations to define LVH. After a median follow-up of 2.90 years, the rates of incident LVH in the normal-weight, overweight, and obese groups were 13.5%, 20.3%, and 27.8%, respectively (<0.001). In reference to normal weight, obesity was associated with increased risk of incident LVH (adjusted hazard ratio [aHR], 2.51 [95% CI, 1.91-3.29]), which was attenuated when achieved SBP was <130 mm Hg (aHR, 1.78 [95% CI, 0.99-3.19]). This association remained significant when achieved SBP was ≥140 mm Hg (aHR, 3.45 [95% CI, 2.13-5.58]) or at 130 to 139 mm Hg (aHR, 2.32 [95% CI, 1.23-4.36]). Differences in these findings were noted when LVH was defined by the American Society of Echocardiography/European Association of Cardiovascular Imaging criteria.

Conclusions: Obesity was associated with incident LVH and an SBP target <130 mm Hg might be needed to attenuate this risk in patients with hypertension and obesity.

References

Litwin S, Adams T, Davidson L, McKinlay R, Simper S, Ranson L . Longitudinal Changes in Cardiac Structure and Function in Severe Obesity: 11-Year Follow-Up in the Utah Obesity Study. J Am Heart Assoc. 2020; 9(12):e014542. PMC: 7429060. DOI: 10.1161/JAHA.119.014542. View

Yildiz M, Oktay A, Stewart M, Milani R, Ventura H, Lavie C . Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis. 2019; 63(1):10-21. DOI: 10.1016/j.pcad.2019.11.009. View

Cuspidi C, Rescaldani M, Sala C, Grassi G . Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens. 2013; 32(1):16-25. DOI: 10.1097/HJH.0b013e328364fb58. View

Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z . Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015. Circulation. 2018; 137(22):2344-2356. DOI: 10.1161/CIRCULATIONAHA.117.032380. View

Hoit B, Litwin S . The New Normal: How Should We Assess Cardiac Chamber Sizes and Proportionality across the Full Spectrum of Body Sizes with Varying Degrees of Adiposity?. J Am Soc Echocardiogr. 2021; 35(2):151-153. DOI: 10.1016/j.echo.2021.11.013. View

El Hajj M, Litwin S . Echocardiography in the Era of Obesity. J Am Soc Echocardiogr. 2020; 33(7):779-787. DOI: 10.1016/j.echo.2020.03.009. View

Bang C, Soliman E, Simpson L, Davis B, Devereux R, Okin P . Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study. Am J Hypertens. 2017; 30(9):914-922. PMC: 5861536. DOI: 10.1093/ajh/hpx067. View

Aurigemma G, de Simone G, Fitzgibbons T . Cardiac remodeling in obesity. Circ Cardiovasc Imaging. 2013; 6(1):142-52. DOI: 10.1161/CIRCIMAGING.111.964627. View

Bluher M . Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019; 15(5):288-298. DOI: 10.1038/s41574-019-0176-8. View

10.

Deng Y, Liu W, Yang X, Guo Z, Zhang J, Huang R . Intensive Blood Pressure Lowering Improves Left Ventricular Hypertrophy in Older Patients with Hypertension: The STEP Trial. Hypertension. 2023; 80(9):1834-1842. PMC: 10424814. DOI: 10.1161/HYPERTENSIONAHA.122.20732. View

11.

Cai A, Liu L, Zhou D, Zhou Y, Tang S, Feng Y . The patterns of left ventricular alteration by adipose tissue distribution: implication for heart failure prevention. ESC Heart Fail. 2021; 8(4):3093-3105. PMC: 8318514. DOI: 10.1002/ehf2.13415. View

12.

Pan X, Wang L, Pan A . Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021; 9(6):373-392. DOI: 10.1016/S2213-8587(21)00045-0. View

13.

Tadic M, Cuspidi C, Marwick T . Phenotyping the hypertensive heart. Eur Heart J. 2022; 43(38):3794-3810. DOI: 10.1093/eurheartj/ehac393. View

14.

Bello N, Cheng S, Claggett B, Shah A, Ndumele C, Roca G . Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities). Circ Heart Fail. 2016; 9(8). PMC: 5218510. DOI: 10.1161/CIRCHEARTFAILURE.115.002978. View

15.

Zhou B . Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002; 15(1):83-96. View

16.

. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304):957-980. PMC: 8446938. DOI: 10.1016/S0140-6736(21)01330-1. View

17.

Zhang T, Li S, Bazzano L, He J, Whelton P, Chen W . Trajectories of Childhood Blood Pressure and Adult Left Ventricular Hypertrophy: The Bogalusa Heart Study. Hypertension. 2018; 72(1):93-101. PMC: 6002936. DOI: 10.1161/HYPERTENSIONAHA.118.10975. View

18.

Johnson K, Oparil S, Davis B, Tereshchenko L . Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study. J Am Heart Assoc. 2019; 8(8):e011961. PMC: 6507192. DOI: 10.1161/JAHA.119.011961. View

19.

von Jeinsen B, Vasan R, McManus D, Mitchell G, Cheng S, Xanthakis V . Joint influences of obesity, diabetes, and hypertension on indices of ventricular remodeling: Findings from the community-based Framingham Heart Study. PLoS One. 2020; 15(12):e0243199. PMC: 7728232. DOI: 10.1371/journal.pone.0243199. View

20.

Chirinos J, Segers P, De Buyzere M, Kronmal R, Raja M, De Bacquer D . Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension. 2010; 56(1):91-8. PMC: 3121539. DOI: 10.1161/HYPERTENSIONAHA.110.150250. View